197 related articles for article (PubMed ID: 16513828)
1. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.
Luque RM; Kineman RD
Endocrinology; 2006 Jun; 147(6):2754-63. PubMed ID: 16513828
[TBL] [Abstract][Full Text] [Related]
2. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
[TBL] [Abstract][Full Text] [Related]
3. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
Luque RM; Gahete MD; Valentine RJ; Kineman RD
J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
5. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
6. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
7. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
8. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
Luque RM; Park S; Kineman RD
Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
Kamegai J; Unterman TG; Frohman LA; Kineman RD
Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
[TBL] [Abstract][Full Text] [Related]
11. Gender-dependent role of endogenous somatostatin in regulating growth hormone-axis function in mice.
Luque RM; Kineman RD
Endocrinology; 2007 Dec; 148(12):5998-6006. PubMed ID: 17761762
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.
Tulipano G; Vergoni AV; Soldi D; Muller EE; Cocchi D
J Endocrinol; 2004 Nov; 183(2):289-98. PubMed ID: 15531717
[TBL] [Abstract][Full Text] [Related]
13. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
[TBL] [Abstract][Full Text] [Related]
14. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
Melián E; Velasco B; Barrios R; Sanchez-Franco F
Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
[TBL] [Abstract][Full Text] [Related]
15. Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH.
Kineman RD; Luque RM
Endocrinology; 2007 Sep; 148(9):4440-9. PubMed ID: 17540720
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
17. Effects of ghrelin administration on decreased growth hormone status in obese animals.
Iwakura H; Akamizu T; Ariyasu H; Irako T; Hosoda K; Nakao K; Kangawa K
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E819-25. PubMed ID: 17595213
[TBL] [Abstract][Full Text] [Related]
18. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
[TBL] [Abstract][Full Text] [Related]
19. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
20. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
